Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease

Recruiting

BudesonideIntra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease

Sponsor:

University of Arizona

Code:

NCT05364385

Conditions

Infant, Extremely Premature

Acute Lung Injury

Chronic Lung Disease of Prematurity

Budesonide

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Interventions

Infants in the study group (S/B group) will receive surfactant 2.5 mls/kg and Budesonide 0.5 mg (1mL)

Infants in the control group (S/P group) receive placebo (Normal saline 1mL)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by University of Arizona on 2022-11-01.